NIH-funded research U01 cooperative agreement

How sex differences in a specific enzyme affect radiation damage in the gastrointestinal system

Official title: Sex-differences in ACE2 Regulate Normal Tissue Toxicity During Gastrointestinal Acute Radiation Syndrome

Funded at Medical College of Wisconsin · NIH-11120957 · Data updated 2026-11-12

This study is looking at how being male or female affects how the body reacts to radiation damage in the gut, focusing on a specific enzyme called ACE2, to find better ways to help people recover from radiation exposure.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMedical College of Wisconsin
NIH-funded
Lab location1 site (Milwaukee, United States)
Project startJune 18, 2024
Project endMay 31, 2027
Funding year2025
Award (this year)$535,440
NIH project number5U01AI183904-02
Project IDNIH-11120957 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would be individuals who have been exposed to radiation and are experiencing gastrointestinal complications.

Less likely to help

Patients who have not been exposed to radiation or do not have gastrointestinal issues may not benefit from this research.

What this research studies

This research investigates how biological sex influences the body's response to gastrointestinal acute radiation syndrome (GI-ARS), focusing on the enzyme ACE2. The study aims to understand why adult male rats are more susceptible to GI-ARS compared to females, exploring the role of ACE2 and its regulation by estrogen. By examining these differences, the research seeks to identify potential treatments that could improve recovery from radiation exposure. The findings could lead to sex-specific medical countermeasures for radiation injuries.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients affected by radiation exposure, particularly in developing sex-specific therapies.

How similar studies have gone: Other studies have shown that understanding sex differences in biological responses can lead to significant advancements in treatment strategies, suggesting potential success for this approach.

Where this research is happening

  • Medical College of Wisconsin
    Milwaukee, United States
    Active

Researchers

  • Principal investigator: Himburg, Heather a — Medical College of Wisconsin
  • Study coordinator: Himburg, Heather a

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.